NewsBenzingaAlamar Biosciences Raises FY2026 Sales Guidance from $116.000M-$120.000M to $121.000M-$123.000M vs $118.632M Est Alamar Biosciences Raises FY2026 Sales Guidance from $116.000M-$120.000M to $121.000M-$123.000M vs $118.632M Est Benzinga 2026.11.03 21:13 (GMT+0) Open on Benzinga Other news Hearing Nvidia Chair Says Jensen Huang Not Coming Back Here’s How Much You Would Have Made Owning KLA Stock In The Last 20 Years Fed Minutes: 'Almost All' Officials See More Hikes, and AI Debt Is Now on the Radar Freedom Broker Maintains Buy on Euroseas, Raises Price Target to $96 Freedom Broker Maintains Buy on JD.com, Lowers Price Target to $40 Freedom Broker Maintains Buy on i-80 Gold, Lowers Price Target to $2.8